Pilot study of mass-screening for Fabry's disease (FD) by measuring globotriaosylceramide (GL-3) in whole urine samples using tandem mass spectrometry (TMS)

• KITAGAWA T

収録刊行物

• J Inherit Metab Dis

  J Inherit Metab Dis 26 (2), 157-, 2003

詳細情報

• CRID: 1573387450162263168
• NII論文ID: 10018717645
• データソース種別:
  • CiNii Articles